Humanigen, Inc. (HGEN) Stock Gaining Momentum in Aftermarket Despite any Visible Reason.
Humanigen. Inc. (HGEN) is a leading late clinical-stage biotherapeutics company engaged in the prevention and treatment an immune-based response known as a cytokine storm. The